NOVOCARE

Serial Number 87800064
Registration 5574983
702

Registration Progress

Application Filed
Feb 16, 2018
Under Examination
Approved for Publication
Jul 17, 2018
Published for Opposition
Jul 17, 2018
Registered
Oct 2, 2018

Basic Information

Serial Number
87800064
Registration Number
5574983
Filing Date
February 16, 2018
Registration Date
October 2, 2018
Published for Opposition
July 17, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Jan 16, 2025
Registration
Registered
Classes
036 044

Rights Holder

Novo Nordisk A/S

99
Address
Novo Allé
Bagsvaerd DK-2880
DK

Ownership History

Novo Nordisk A/S

Original Applicant
99
DK-2880 Bagsvaerd DK

Novo Nordisk A/S

Owner at Publication
99
DK-2880 Bagsvaerd DK

Novo Nordisk A/S

Original Registrant
99
Bagsvaerd DK

Legal Representation

Attorney
/Spencer Beall/

USPTO Deadlines

Next Deadline
1181 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-10-02)
Due Date
October 02, 2028
Grace Period Ends
April 02, 2029

Application History

14 events
Date Code Type Description
Jan 16, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 16, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 16, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 23, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED
Oct 2, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 2, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 7, 2018 DOCK D ASSIGNED TO EXAMINER
Jul 17, 2018 PUBO A PUBLISHED FOR OPPOSITION
Jul 17, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 27, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2018 DOCK D ASSIGNED TO EXAMINER
Feb 24, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 20, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 036
Providing financial assistance to patients and healthcare providers for prescription drug costs in the field of metabolic disorders; providing information about patient reimbursement and insurance coverage for pharmaceuticals
First Use Anywhere: Dec 11, 2017
First Use in Commerce: Dec 11, 2017
Class 044
Charitable services, namely, patient assistance program to provide drugs free of charge to low-income patients without prescription drug coverage
First Use Anywhere: Dec 11, 2017
First Use in Commerce: Dec 11, 2017

Additional Information

Pseudo Mark
NOVO CARE

Classification

International Classes
036 044